What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News 'El País Semanal' highlights Dr. Guarner as one of the 'Bacteria's tamers' When we listen the word "bacterium" begin to tremble. Some of them have well-taken bad reputation, but many others are indispensable for the life. Groups of scientists, with several Spanish standing out, investigate to discover and to control the map of this microuniverse. To solve so widespread and News Onda Cero radio talks about VHIR's innovations project The radio show 'Pont Barcelona-Madrid' of Onda Cero radio interviewed on Thursday 1st March Raquel Egea, coordinator of the innovation unit at Vall d'Hebron Research Institute (VHIR). During the interview she spoke about the bet for the innovation to value the knowledge and make arrive to the patien News 'The Master of TV3' and the research on spina bifida at VHIR José Escrig and Anabé Manzano are two students of 'The Master of TV3 ', who collaborated during the course with investigators of Vall d'Hebron Research Institute (VHIR) with the aim of having an experience in the field of the scientific journalism. The students lived through the study on the correct News Second course of basic foundations in mechanical ventilation On March 1, 2 and 3 at Vall d'Hebron University Hospital (HUVH) has been celebrated the second edition of the course of basic foundations in mechanical ventilation (Ventilung), organized by the group of clinical research, innovation in the pneumonia & sepsis (CRIPS) at Vall d'Hebron Research Institu News World Rare Diseases Day at VHIR Vall d'Hebron University Hospital is a national and international reference center to the study of the rare diseases, which on February 29 celebrate the World Day. Many of our clinical groups are experts recognized in this type of diseases. Fruit of this clinical activity, Vall d'Hebron Research Ins News A study determines the efficiency in clinical practice of an injectable treatment for the multiple sclerosis A study with the participation of Vall d'Hebron Research Institute (VHIR) and the Center of Multiple sclerosis of Catalonia (CEM-Cat) together with 85 more centers of Spain determines that the therapy with Natalizumab is effective in the treatment of the multiple sclerosis. The study has evaluated t News The USP15 Biological Thermostat: a Promising Novel Therapeutic Target in Cancer After years studying the molecular bases of glioblastoma - the most common brain tumor and one of the most aggressive of all cancers, the group led by Dr. Joan Seoane , Director of Translational Research at the Vall d’Hebron Institute of Oncology (VHIO) and ICREA Research Professor has today publis News VHIR's director participates in the 5th Annual Conference of the Technological Platforms of Biomedical Research The director of Vall d'Hebron Research Institute (VHIR), Dr. Joan Comella, has participated in 5th Annual Conference of the Technological Platforms of Biomedical Research: Innovative Medicines, Nanomedicina, Sanitary Technology and Biotechnological Markets, Promoting the Open Innovation held in Barc News The Society of Critical Care Medicine awards VHIR's researchers A joint work of researchers from Vall d'Hebron Research Institute (VHIR) has received the '2012 Annual Cardiovascular Speciality award' for its outstanding research contributions to the Society of Critical Care Medicine. The abstract, entitled 'Innovative continous non invasive cuffless blood pressu News 5th SMD Integrated Diagnostic Workshop Cytology, Immunophenotype and cytogenetics Units of Hematology from Vall d'Hebron University Hospital organized on February 7 the Fifth Integrated Diagnostics Workshop Myelodysplastic Syndromes (MDS) of clinical cases.The fifth edition of the workshop, led by Dr Teresa Vallespí, member of the experi News Dr. Margarita Salas opens on March 9 the 1st edition of 'Women and Science' at VHIR VHIR will organize in March the first edition of the cycle 'Women and Science'. Structured in four meetings in four consecutive weeks, the opening session will take place on March 9 with the conference 'Woman and Science: my own experience' by Dr. Margarita Salas, who has dedicated all her life to s News VHIR's researchers participate in TVE's debate on inflammatory intestinal diseases The inflammatory intestinal diseases are increasing in the developed countries. To know for what reason and to be able to face them better, researchers from Vall d'Hebron Research Institute (VHIR) are studying the bacteria of the human intestine. To talk about it, Dr. Francisco Guarner, from the res News BMV course on Clinical Excellence in Cardiology During January 26th and 27th, more tan 200 cardiologists have visited Vall d’Hebron University Hospital (HUVH) to attend the 2nd edition of the "BMV course on Clinical Excellence in Cardiology". The BMV course is a joint initiative of the Services of Cardiology of HUVH, Hospital General Universitari News An international study with participation of Vall d'Hebron reveals RAS mutations associated to BRAF inhibitors The treatment of the melanoma with BRAF inhibitors has obtained big successes but it has taken as a not wished effect the development of secondary tumours, scaly carcinomas well differentiated and queratoacantomas. An international study reveals the high frequency of mutations of RAS in this type o News Running for stroke The Stroke Unit at Vall d'Hebron University Hospital (HUVH) and the neurovascular diseases group at Vall d’Hebron Research Institute (VHIR) team together to run the Half Marathon of Barcelona on February 26 and to raise funds for the research in silent strokes.The idea came from the Stroke Unit at H News Dr. Guarner explains the keys of the microbioma in the journal 'Publico' The project Human Genome sequenced the genetic information contained in 10% of the cells that form the human body. The remaining 90% aren't human cells but an authentic ecosystem of approximately hundred trillions of bacteria living in our body. They receive the name of microbioma, and science is di News An international study determines Firategrast's efficiency, an oral medicament for the treatment of the multiple sclerosis An international research in which have participated Vall d'Hebron Research Institute (VHIR) and the Center of Multiple sclerosis of Catalonia (CEM-Cat) determines that the therapy with firategrast, an oral medicament anti a4b-integrina, is effective in the treatment of the multiple sclerosis. The s News VHIR and CRG to collaborate in basic and clinical research projects The Centre for Genomic Regulation (CRG) and the Vall d'Hebron Research Institute (VHIR) have signed an agreement for the development of collaborative projects in basic and clinical research. One of the proposed focuses is research on rare genetic diseases.The agreement, signed by the directors of th News VHIR's research identifies a new suppressing gene of colorectal tumors The CIBBIM-Nanomedicine-Molecular Oncology group at Vall d'Hebron Research Institute (VHIR) has identified the role of a gene -the Myosina 1a or MYO1A- in the appearance of the colorectal cancer. What until now was known as a gene without too much importance and responsible of part of the internal s News VHIR's research proves why the sexual hormones diminish in diabetic and obese people The group of Diabetes and Metabolism at Vall d'Hebron Research Institute (VHIR) has determined for the first time a link between the inflammation of low degree, typical of the people with obesity and/or diabetes type II, and the low levels of the SHBG (sex hormone-binding globular) or transport prot Pagination First page « Previous page ‹ … Page 149 Page 150 Current page 151 Page 152 Page 153 … Next page › Last page »
